TRIPODO, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 10.523
NA - Nord America 8.975
EU - Europa 7.113
SA - Sud America 840
AF - Africa 163
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 3
Totale 27.684
Nazione #
US - Stati Uniti d'America 8.585
CN - Cina 3.916
SG - Singapore 2.585
IT - Italia 1.981
DE - Germania 1.619
HK - Hong Kong 1.175
BD - Bangladesh 841
GB - Regno Unito 660
BR - Brasile 624
VN - Vietnam 590
FR - Francia 579
RU - Federazione Russa 556
FI - Finlandia 433
JP - Giappone 353
IN - India 336
NL - Olanda 265
CA - Canada 211
SE - Svezia 201
ES - Italia 189
KR - Corea 181
MX - Messico 115
IE - Irlanda 108
TR - Turchia 95
AR - Argentina 76
ID - Indonesia 76
TW - Taiwan 73
DK - Danimarca 65
PL - Polonia 61
AU - Australia 60
CH - Svizzera 54
BE - Belgio 51
UA - Ucraina 47
PT - Portogallo 44
AT - Austria 43
CI - Costa d'Avorio 41
CO - Colombia 38
IQ - Iraq 38
EG - Egitto 33
IR - Iran 31
PH - Filippine 28
VE - Venezuela 28
NO - Norvegia 26
MY - Malesia 25
LV - Lettonia 23
CL - Cile 21
PK - Pakistan 19
EC - Ecuador 18
GR - Grecia 18
PE - Perù 18
ZA - Sudafrica 17
HU - Ungheria 16
IL - Israele 16
MA - Marocco 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
KE - Kenya 15
TH - Thailandia 15
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
RO - Romania 13
JM - Giamaica 12
EU - Europa 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
NG - Nigeria 9
PY - Paraguay 8
AZ - Azerbaigian 7
BG - Bulgaria 7
CY - Cipro 7
LU - Lussemburgo 7
NP - Nepal 7
NZ - Nuova Zelanda 7
PR - Porto Rico 7
AL - Albania 6
JO - Giordania 6
KZ - Kazakistan 6
LK - Sri Lanka 6
LB - Libano 5
OM - Oman 5
PS - Palestinian Territory 5
RS - Serbia 5
SI - Slovenia 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
MO - Macao, regione amministrativa speciale della Cina 4
NI - Nicaragua 4
PA - Panama 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
HN - Honduras 3
KW - Kuwait 3
LT - Lituania 3
SV - El Salvador 3
Totale 27.641
Città #
Dallas 2.457
Frankfurt am Main 1.043
Singapore 1.025
Hong Kong 827
Ashburn 777
San Jose 684
Santa Clara 567
Milan 500
Hefei 484
Southend 436
Council Bluffs 367
Helsinki 347
Beijing 315
Guangzhou 262
Hanover 257
Los Angeles 257
Lauterbourg 223
Ho Chi Minh City 190
New York 184
Shanghai 181
Hanoi 163
Bengaluru 157
Chandler 155
Moscow 153
Seattle 141
Rome 130
Buffalo 122
Tokyo 110
Seoul 103
Shenzhen 103
Dublin 102
Fairfield 98
Hangzhou 97
Nanjing 87
Boardman 82
Paris 80
Tianjin 72
Chicago 70
São Paulo 70
Houston 69
Wilmington 69
Princeton 65
Palermo 62
Chengdu 60
Naples 59
Ann Arbor 58
Toronto 58
Jakarta 55
Madrid 55
Stanford 52
Atlanta 51
Lappeenranta 51
Washington 51
Cambridge 49
Munich 49
Redwood City 49
Woodbridge 49
Columbus 47
Wuhan 44
Zhengzhou 44
Changsha 43
Florence 42
Abidjan 41
Shenyang 41
Bologna 40
Cangzhou 40
Jinan 40
Nuremberg 38
Turin 38
London 37
The Dalles 37
Amsterdam 35
Boston 35
Istanbul 34
Chongqing 33
Dearborn 33
Phoenix 33
Taipei 31
McAllen 29
Mexico City 29
San Francisco 29
Da Nang 28
Haiphong 28
Des Moines 27
Fuzhou 27
Nanchang 27
Vienna 27
Sydney 25
Xi'an 25
Harbin 24
Mooresville 24
Mumbai 24
Vancouver 24
Warsaw 24
Central 23
Denver 22
Montreal 22
Pittsburgh 22
Rio de Janeiro 22
Berlin 20
Totale 15.847
Nome #
Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer 3.089
Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma 1.210
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-Small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade 964
HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma 724
IRSp53 controls plasma membrane shape and polarized transport at the nascent lumen in epithelial tubules 455
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 395
ATR expands embryonic stem cell fate potential in response to replication stress 339
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 322
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 318
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 304
Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma 297
Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ 284
The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress 279
B cell receptor silencing reveals origin and dependencies of high-grade B cell lymphomas with MYC and BCL2 rearrangements 264
Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment 264
YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING 259
Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion 255
Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC 253
Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects 241
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 224
miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of tumor cells in triple-negative breast cancer 219
A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia 217
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis 208
A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements 206
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting 204
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 203
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer 198
Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer 197
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells 193
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion 189
Splenic marginal zone lymphoma : a prognostic model for clinical use 188
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models 186
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease 176
Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450) 174
Neutrophils mediate protection against colitis and carcinogenesis by controlling bacterial invasion and IL-22 production by γδ T cells 169
Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer 169
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 163
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions 162
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth 159
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 155
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 145
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 145
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 144
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome 144
Mechanical stress during confined migration causes aberrant mitoses and c-MYC amplification 142
Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models 141
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer 135
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice 132
Response-guided ABDV chemotherapy y plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era : A Gruppo italiano studio linfomi (GISL) prospective trial 131
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer 129
Predictive and prognostic molecular factors in diffuse large b-cell lymphomas 128
Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue 125
Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9 124
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment 124
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms 123
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target 122
The role of inflammation in lymphoma 118
Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: two mixing fatal syndromes? 117
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia 117
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells 116
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 115
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients 115
Extraction of a stromal metastatic gene signature in breast cancer via spatial profiling 114
The bone marrow stroma in hematological neoplasms-a guilty bystander 113
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells 113
Mast cells crosstalk with B cells in the gut and sustain IgA response in the inflamed intestine 110
HER2 signaling and breast cancer stem cells: the bridge behind HER2-positive breast cancer aggressiveness and therapy refractoriness 108
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS 106
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta 105
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction 105
CK2β-regulated signaling controls B cell differentiation and function 103
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy 103
Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming 102
Iron capture through CD71 drives perinatal and tumor-associated Treg expansion 101
Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities 100
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study 100
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 99
The good and bad of targeting cancer-associated extracellular matrix 99
T cells expressing receptor recombination/revision machinery are detected in the tumor microenvironment and expanded in genomically over-unstable models AC 98
Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations 98
Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche 97
Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift 97
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function 96
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism 94
COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis 94
Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity 93
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death 93
The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance 92
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 91
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8 90
Wnt3a neutralization enhances T-cell responses through indirect mechanisms and restrains tumor growth 87
Biocompatibility and biodegradability of electrospun PHEA-PLA scaffolds: our preliminary experience in a murine animal model 87
Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects 87
The aryl hydrocarbon receptor modulates acute and late mast cell responses 87
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 86
A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas 85
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response 85
The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma 84
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone 83
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 83
Totale 20.975
Categoria #
all - tutte 63.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/20221.564 69 94 112 179 150 165 151 136 194 100 88 126
2022/20231.106 103 93 72 101 111 121 66 55 115 55 84 130
2023/20242.216 119 156 116 145 220 140 222 222 133 238 262 243
2024/20254.442 238 252 232 242 188 161 554 464 325 408 488 890
2025/202617.523 846 963 3.526 1.489 1.122 1.014 1.486 951 1.741 921 1.621 1.843
Totale 28.784